Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Margolin

Showing results (351-360 of 406) with videos related to

Pageof 41
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 1996
In vivo purging with high-dose cytarabine followed by high-dose chemoradiotherapy and reinfusion of unpurged bone marrow for adult acute myelogenous leukemia in first complete remissionA S Stein, M R O'Donnell, A Chai, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 4, 2010
Cytokine working group study of lymphodepleting chemotherapy, interleukin-2, and granulocyte-macrophage colony-stimulating factor in patients with metastatic melanoma: clinical outcomes and peripheral-blood cell recoveryKrishna S Gunturu, Kenneth R Meehan, Todd A Mackenzie, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 3, 2014
Nivolumab for Metastatic Renal Cell Carcinoma: Results of a Randomized Phase II TrialRobert J Motzer, Brian I Rini, David F McDermott, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 25, 2009
Phase II studies of gemcitabine and cisplatin in heavily and minimally pretreated metastatic breast cancerHelen K Chew, James H Doroshow, Paul Frankel, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 8, 1999
Interleukin-2-activated autologous bone marrow and peripheral blood stem cells in the treatment of acute leukemia and lymphomaK A Margolin, K Van Besien, C Wright, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 4, 2009
Identifying the proteins to which small-molecule probes and drugs bind in cellsShao-En Ong, Monica Schenone, Adam A Margolin, et al.
Journal of the American Medical Informatics Association : JAMIA|July 16, 2015
The NIH BD2K center for big data in translational genomicsBenedict Paten, Mark Diekhans, Brian J Druker, et al.
Cancer|March 24, 2017
A phase 2 trial of dasatinib in patients with locally advanced or stage IV mucosal, acral, or vulvovaginal melanoma: A trial of the ECOG-ACRIN Cancer Research Group (E2607)Kevin Kalinsky, Sandra Lee, Krista M Rubin, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|October 23, 2013
A phase II study of bevacizumab and high-dose interleukin-2 in patients with metastatic renal cell carcinoma: a Cytokine Working Group (CWG) studyUday B Dandamudi, Musie Ghebremichael, Jeffrey A Sosman, et al.
Nature Methods|May 19, 2015
Combining tumor genome simulation with crowdsourcing to benchmark somatic single-nucleotide-variant detectionAdam D Ewing, Kathleen E Houlahan, Yin Hu, et al.
Pageof 41

Showing results (351-360 of 406) with videos related to

Sort By:
Pageof 41
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 1996
In vivo purging with high-dose cytarabine followed by high-dose chemoradiotherapy and reinfusion of unpurged bone marrow for adult acute myelogenous leukemia in first complete remissionA S Stein, M R O'Donnell, A Chai, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 4, 2010
Cytokine working group study of lymphodepleting chemotherapy, interleukin-2, and granulocyte-macrophage colony-stimulating factor in patients with metastatic melanoma: clinical outcomes and peripheral-blood cell recoveryKrishna S Gunturu, Kenneth R Meehan, Todd A Mackenzie, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 3, 2014
Nivolumab for Metastatic Renal Cell Carcinoma: Results of a Randomized Phase II TrialRobert J Motzer, Brian I Rini, David F McDermott, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 25, 2009
Phase II studies of gemcitabine and cisplatin in heavily and minimally pretreated metastatic breast cancerHelen K Chew, James H Doroshow, Paul Frankel, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 8, 1999
Interleukin-2-activated autologous bone marrow and peripheral blood stem cells in the treatment of acute leukemia and lymphomaK A Margolin, K Van Besien, C Wright, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 4, 2009
Identifying the proteins to which small-molecule probes and drugs bind in cellsShao-En Ong, Monica Schenone, Adam A Margolin, et al.
Journal of the American Medical Informatics Association : JAMIA|July 16, 2015
The NIH BD2K center for big data in translational genomicsBenedict Paten, Mark Diekhans, Brian J Druker, et al.
Cancer|March 24, 2017
A phase 2 trial of dasatinib in patients with locally advanced or stage IV mucosal, acral, or vulvovaginal melanoma: A trial of the ECOG-ACRIN Cancer Research Group (E2607)Kevin Kalinsky, Sandra Lee, Krista M Rubin, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|October 23, 2013
A phase II study of bevacizumab and high-dose interleukin-2 in patients with metastatic renal cell carcinoma: a Cytokine Working Group (CWG) studyUday B Dandamudi, Musie Ghebremichael, Jeffrey A Sosman, et al.
Nature Methods|May 19, 2015
Combining tumor genome simulation with crowdsourcing to benchmark somatic single-nucleotide-variant detectionAdam D Ewing, Kathleen E Houlahan, Yin Hu, et al.
Pageof 41